# Bertrand Brieau

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bertrand-brieau/

## Facts

| Field | Value |
| --- | --- |
| Citations | 755 |
| Field | Gastric Cancer Management and Outcomes |
| h-index | 14 |
| i10-index | 14 |
| Last Known Institution | IRT Jules Verne |
| OpenAlex ID | https://openalex.org/A5064721547 |
| ORCID iD | 0000-0002-4079-1746 |
| Works | 89 |

## Researcher papers

- [An international study on the use of peroral endoscopic myotomy in the management of Zenker’s diverticulum](https://scholariq.org/papers/an-international-study-on-the-use-of-peroral-endoscopic-myotomy-in-the/)
- [Second‐line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine‐platinum combination: A large multicenter study by the Association des Gastro‐Entérologues Oncologues](https://scholariq.org/papers/second-line-chemotherapy-for-advanced-biliary-tract-cancer-after-failure-of-the/)
- [Immune Checkpoint Inhibitor-Induced Colitis: Diagnosis and Management](https://scholariq.org/papers/immune-checkpoint-inhibitor-induced-colitis-diagnosis-and-management/)
- [High risk of myelodysplastic syndrome and acute myeloid leukemia after 177Lu-octreotate PRRT in NET patients heavily pretreated with alkylating chemotherapy](https://scholariq.org/papers/high-risk-of-myelodysplastic-syndrome-and-acute-myeloid-leukemia-after-177lu/)
- [Submucosal tunneling endoscopic septum division for Zenker’s diverticulum: a reproducible procedure for endoscopists who perform peroral endoscopic myotomy](https://scholariq.org/papers/submucosal-tunneling-endoscopic-septum-division-for-zenker-s-diverticulum-a/)
- [Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations](https://scholariq.org/papers/prediction-of-survival-with-second-line-therapy-in-biliary-tract-cancer/)
- [Addition of an antiangiogenic therapy, bevacizumab, to gemcitabine plus oxaliplatin improves survival in advanced biliary tract cancers](https://scholariq.org/papers/addition-of-an-antiangiogenic-therapy-bevacizumab-to-gemcitabine-plus/)
- [Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma](https://scholariq.org/papers/radiochemotherapy-versus-surgery-in-nonmetastatic-anorectal-neuroendocrine/)
- [Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer](https://scholariq.org/papers/fluropyrimidine-single-agent-or-doublet-chemotherapy-as-second-line-treatment-in/)
- [Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre study](https://scholariq.org/papers/efficacy-of-modern-chemotherapy-and-prognostic-factors-in-patients-with-ovarian/)
- [Contribution of the EyeMAX™ 11Fr (Micro-Tech) digital single-operator cholangioscope with a wide working channel: a multicenter pilot study on the first French experiences](https://scholariq.org/papers/contribution-of-the-eyemaxtm-11fr-micro-tech-digital-single-operator/)

## Researcher topics

- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)
- [Esophageal and GI Pathology](https://scholariq.org/topics/esophageal-and-gi-pathology/)
- [Gastrointestinal Tumor Research and Treatment](https://scholariq.org/topics/gastrointestinal-tumor-research-and-treatment/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Gallbladder and Bile Duct Disorders](https://scholariq.org/topics/gallbladder-and-bile-duct-disorders/)

## Researcher university

- [IRT Jules Verne](https://scholariq.org/institutions/irt-jules-verne/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.